Jazz Pharmaceuticals plc (JAZZ)
NGS · Common · CUSIP G50871105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for JAZZ and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
G50871105 (prev. 00B4Q5ZN4 )
Market Cap
Large Cap · $6 Billion
Business: Jazz Pharmaceuticals plc is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients. Their unwavering commitment to advancing patient care is demonstrated every day. As a leader in sleep medicine and with a growing hematology/oncology portfolio, they develop meaningful medicines and bring them to people with unaddressed needs around the world. Headquartered in Dublin, Ireland with locations in California and Pennsylvania, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals. Jazz Pharmaceuticals markets a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Company Contact

CEO
Bruce C. Cozadd
CFO
Renée Galá
Investor Relations
650-496-2800 · investorinfo@jazzpharmaceuticals.com
General Email
contact@jazzpharma.com
Email Form
Request Form »
SEC EDGAR Filings
View filings »